RAPT Therapeutics (FRA:0RA) Total Stockholders Equity : €164.07 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is RAPT Therapeutics Total Stockholders Equity?

RAPT Therapeutics's Total Stockholders Equity for the quarter that ended in Mar. 2025 was €164.07 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. RAPT Therapeutics's Book Value per Share for the quarter that ended in Mar. 2025 was €1.24. The ratio of a company's debt over equity can be used to measure how leveraged this company is. RAPT Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.02.

RAPT Therapeutics Total Stockholders Equity Historical Data

The historical data trend for RAPT Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RAPT Therapeutics Total Stockholders Equity Chart

RAPT Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

85.64

164.95

231.44

134.83

181.36

RAPT Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															120.37	101.47	86.05	181.36	164.07

RAPT Therapeutics (FRA:0RA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

RAPT Therapeutics's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(164.069	-	0)	/	132.007
	=	1.24

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

RAPT Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.141	+	1.406)	/	164.069
	=	0.02

RAPT Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of RAPT Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

RAPT Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RAPT Therapeutics Inc (FRA:0RA) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

RAPT:USA

Address

561 Eccles Avenue, South San Francisco, CA, USA, 94080

Website

https://www.rapt.com

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

RAPT Therapeutics Headlines

No Headlines